Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
FDA Grants Orphan Drug Designation for MediGenes Drug Candidate EndoTAG-1
MediGene, 05/21/09
MediGene AG has obtained orphan drug designation from the US regulatory authority FDA for paclitaxel, the active ingredient in MediGene's drug candidate EndoTAG-1 for the indication pancreatic cancer. Orphan drug designation for EndoTAG-1 in this indication was already granted in the European Union in 2006.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Article Search
Sponsor